Date,Title,Source
2025-10-16T05:49:07Z,Cantor Fitzgerald Reaffirms Overweight Rating on AbbVie (ABBV),Yahoo Entertainment
2025-10-13T21:11:40Z,"If You Invested $100 In AbbVie Stock 10 Years Ago, You Would Have This Much Today",Biztoc.com
"Fri, 17 Oct 2025 03:26:48 GMT",What to do if you’re stuck in ABBV - Market Risk Analysis & Expert-Curated Trade Recommendations - newser.com,newser.com
"Thu, 16 Oct 2025 21:58:48 GMT",AbbVie (ABBV) Faces Legal Challenge Amid Stock Recovery - GuruFocus,GuruFocus
"Wed, 15 Oct 2025 21:45:00 GMT",AbbVie (ABBV) Stock Falls Amid Market Uptick: What Investors Need to Know - Nasdaq,Nasdaq
"Thu, 16 Oct 2025 05:49:00 GMT",Cantor Fitzgerald Reaffirms Overweight Rating on AbbVie (ABBV) - Yahoo,Yahoo
"Tue, 14 Oct 2025 02:58:58 GMT",Academic–Industrial Collaboration in Synthesis with Real-Time Impact in Medicinal Chemistry: Discovery of Cystic Fibrosis C2 Corrector ABBV-602 - ACS Publications,ACS Publications
"Mon, 13 Oct 2025 11:15:00 GMT",AbbVie to Present New Data at ESMO 2025 Reinforcing Leadership in Advancing Targeted Therapies for Solid Tumors - PR Newswire,PR Newswire
"Wed, 15 Oct 2025 12:32:02 GMT",(ABBV) Risk Channels and Responsive Allocation - news.stocktradersdaily.com,news.stocktradersdaily.com
"Wed, 15 Oct 2025 11:31:00 GMT","Wells Fargo Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $260 - 富途牛牛",富途牛牛
"Tue, 14 Oct 2025 17:11:23 GMT",AbbVie (ABBV): Assessing Valuation After Strong 28% Year-to-Date Share Price Jump - Yahoo Finance,Yahoo Finance
"Mon, 13 Oct 2025 11:15:00 GMT",AbbVie to Present New Data at ESMO 2025 Reinforcing Leadership in Advancing Targeted Therapies for Solid Tumors - Stock Titan,Stock Titan
"Thu, 16 Oct 2025 20:19:56 GMT",What to do if you’re stuck in ABBV - July 2025 Catalysts & Consistent Income Trade Recommendations - newser.com,newser.com
"Mon, 13 Oct 2025 09:37:33 GMT",AbbVie Inc. (ABBV) Stock Analysis: Evaluating a Healthcare Giant with a Robust 112.85% Return on Equity - DirectorsTalk Interviews,DirectorsTalk Interviews
"Wed, 15 Oct 2025 12:32:26 GMT",AbbVie (ABBV) Pursues Acquisition Amid Patent Dispute Over Breti - GuruFocus,GuruFocus
"Tue, 14 Oct 2025 19:33:00 GMT","Noteworthy Tuesday Option Activity: DBRG, ABBV, PINS - Nasdaq",Nasdaq
"Mon, 13 Oct 2025 14:57:00 GMT",Use after 1 approved systemic therapy — AbbVie gets FDA approval to update RINVOQ IBD label allowing pre‑TNF use - Stock Titan,Stock Titan
"Tue, 14 Oct 2025 10:53:28 GMT",Cantor Fitzgerald Notes IPR&D Charge Impact on Abbvie's (ABBV) 3Q EPS - StreetInsider,StreetInsider
"Mon, 13 Oct 2025 16:14:31 GMT",FDA Expands AbbVie's Rinvoq (ABBV) Indication for Colitis and Cr - GuruFocus,GuruFocus
"Mon, 13 Oct 2025 14:02:00 GMT",Erste Group Downgrades Abbvie (ABBV) to Hold - StreetInsider,StreetInsider
"Tue, 14 Oct 2025 12:17:04 GMT","Amazon, AbbVie, Datadog And A Financial Stock: CNBC's 'Final Trades' - Benzinga",Benzinga
"Mon, 13 Oct 2025 15:37:52 GMT",FDA Expands AbbVie's (ABBV) RINVOQ Approval for Ulcerative Colit - GuruFocus,GuruFocus
"Wed, 15 Oct 2025 01:26:13 GMT",What AbbVie’s Bretisilocin Acquisition Means for Its Share Price in 2025 - simplywall.st,simplywall.st
"Thu, 16 Oct 2025 20:52:52 GMT",AbbVie ends in green six straight sessions of declines - Seeking Alpha,Seeking Alpha
"Tue, 14 Oct 2025 16:13:56 GMT",Can Rinvoq and Skyrizi Sales Drive Another Strong Quarter for AbbVie? - The Globe and Mail,The Globe and Mail
"Mon, 13 Oct 2025 16:21:00 GMT",AbbVie Stock Rises After FDA Approves Changed Recommendations For Use Of Popular Rinvoq Drug - MSN,MSN
"Mon, 13 Oct 2025 15:54:26 GMT",Is AbbVie (ABBV) a Buy as Wall Street Analysts Look Optimistic? - MSN,MSN
"Tue, 14 Oct 2025 07:04:48 GMT",AbbVie Inc. (NYSE:ABBV) Receives Average Rating of “Moderate Buy” from Analysts - Defense World,Defense World
2025-10-16T07:49:07,Cantor Fitzgerald Reaffirms Overweight Rating on AbbVie (ABBV),Yahoo
2025-10-15T23:45:05,AbbVie (ABBV) Stock Falls Amid Market Uptick: What Investors Need to Know,Yahoo
2025-10-15T14:30:13,Enveric Biosciences hires Fish & Richardson to defend patent tied to AbbVie deal,Yahoo
2025-10-15T14:00:00,"Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent with Claims Relevant to Bretisilocin, Recently Acquired by AbbVie in $1.2 Billion Deal",Yahoo
2025-10-14T19:11:23,AbbVie (ABBV): Assessing Valuation After Strong 28% Year-to-Date Share Price Jump,Yahoo
2025-10-14T17:09:00,Can Rinvoq and Skyrizi Sales Drive Another Strong Quarter for AbbVie?,Yahoo
2025-10-14T12:09:56,Does AbbVie's Latest AI Partnership Signal More Room for Its 2025 Rally?,Yahoo
2025-10-13T16:57:00,U.S. Food and Drug Administration (FDA) Approves Updated Indication Statement for RINVOQ® (upadacitinib) for the Treatment of Inflammatory Bowel Disease,Yahoo
2025-10-13T13:31:00,AbbVie Gets Expanded FDA Approval for Rinvoq Drug,MarketWatch
2025-10-13T13:15:00,AbbVie to Present New Data at ESMO 2025 Reinforcing Leadership in Advancing Targeted Therapies for Solid Tumors,Yahoo
